The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) has announced updated guidelines on how to
Of the nearly 100 million Americans living with diabetes or prediabetes, a large percentage will seek a driver’s license or are already
Eli Lilly and Company’s investigational two-in-one diabetes drug showed both meaningful blood sugar reduction and significant weight loss in
A weight loss drug, lorcaserin, was found to reduce the risk of diabetes by 19 percent in patients with prediabetes in a recent study. The drug is
Severe hypoglycemia has much more serious consequences in people who have both diabetes and dementia than those with diabetes alone, according to new
Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada.
Novo Nordisk announced plans to launch its first “smart” insulin pens next year. In addition, to integrate it smartpens with broader
A well-known gene variant linked to Type 2 diabetes may also predispose people to have lower body weight, new research finds. The contradictory
Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients
People living with diabetes in Europe will now have the choice to be alerted in real-time of hypoglycemia (low glucose levels) or hyperglycemia
Get a little dLife delivered to your inbox every week.